Notably, while the NF-κB/MAPK pathways are activated in DM–TB (Figure 4B), our data reveal significant reductions in adaptive immune cell populations, such as CD8+ T cells and memory B cells (Figure 10A). This evidence concerns the gene NFKB1 and diabetes mellitus.